Modern aspects of nonalcoholic fatty liver disease patients treatment
Author:
Publisher
LLC Obyedinennaya Redaktsiya
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CYTOKINE BLOOD PROFILE IN PATIENTS WITH DIFFUSE LIVER DISEASE COMBINED WITH EPSTEIN-BARR VIRUS AND SECONDARY IMMUNODEFICIENCY;Ulyanovsk Medico-biological Journal;2023-07-03
2. Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy;Rational Pharmacotherapy in Cardiology;2022-01-12
3. Experience of using telmisartan, atorvastatin and ursodeoxycholic acid in patients with arterial hypertension in combination with non-alcoholic fatty liver disease;Сибирский научный медицинский журнал;2021-10-28
4. Clinical features of the comorbid course of non-alcoholic fatty liver disease and gallstone disease;Terapevticheskii arkhiv;2020-09-03
5. Features of the course of gallstone disease in patients with non-alcoholic fatty liver disease;Terapevticheskii arkhiv;2020-02-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3